Safety and Efficacy of Idasanutlin in Patients (pts) with Hydroxyurea (HU)-Resistant/Intolerant Polycythemia Vera (PV): Results of an International Phase II Study

被引：7
|
作者：
Mascarenhas, John
Higgins, Brian
Anders, Doreen
Burbury, Kate
El-Galaly, Tarec Christoffer
Gerds, Aaron T.
Gupta, Vikas
Kovic, Bruno
Maffioli, Margherita
Mesa, Ruben
Palmer, Jeanne M.
Passamonti, Francesco
Rambaldi, Alessandro
Ross, David M.
Vannucchi, Alessandro M.
Yacoub, Abdulraheem
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-135868
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Durable Responses with the JAK1/JAK2 Inhibitor, INCB018424, In Patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory or Intolerant to Hydroxyurea (HU)
    Verstovsek, Srdan
    Passamonti, Francesco
    Rambaldi, Alessandro
    Barosi, Giovanni
    Rosen, Peter J.
    Levy, Richard
    Bradley, Edward
    Garrett, William
    Vaddi, Kris
    Contel, Nancy
    Sandor, Victor
    Huber, Reid Michael
    Schacter, Lee P.
    Rumi, Elisa
    Gattoni, Elisabetta
    Antonioli, Elisabetta
    Pieri, Lisa
    Cazzola, Mario
    Kantarjian, Hagop
    Barbui, Tiziano
    Vannucchi, Alessandro M.
    BLOOD, 2010, 116 (21) : 142 - 143
  • [42] Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available
    Foltz, Lynda
    Pica, Gian-Matteo
    Zerazhi, Hacene
    Van Droogenbroeck, Jan
    Visanica, Sorin
    de la Fuente, Enrique Baez
    Leber, Brian
    de Almeida, Antonio Medina
    Ranta, Dana
    Kiladjian, Jean-Jacques
    Chrit, Linda
    Kandra, Albert
    Morando, Juliane
    Devos, Timothy
    LEUKEMIA & LYMPHOMA, 2019, 60 (14) : 3493 - 3502
  • [43] Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study
    Palandri, Francesca
    Rossi, Elena
    Auteri, Giuseppe
    Breccia, Massimo
    Paglia, Simona
    Benevolo, Giulia
    Elli, Elena M.
    Cavazzini, Francesco
    Binotto, Gianni
    Tieghi, Alessia
    Tiribelli, Mario
    Heidel, Florian H.
    Bonifacio, Massimiliano
    Pugliese, Novella
    Caocci, Giovanni
    Crugnola, Monica
    Mendicino, Francesco
    D'Addio, Alessandra
    Tomassetti, Simona
    Martino, Bruno
    Polverelli, Nicola
    Ceglie, Sara
    Mazzoni, Camilla
    Mullai, Rikard
    Ripamonti, Alessia
    Garibaldi, Bruno
    Pane, Fabrizio
    Cuneo, Antonio
    Krampera, Mauro
    Semenzato, Gianpietro
    Lemoli, Roberto M.
    Vianelli, Nicola
    Palumbo, Giuseppe A.
    Andriani, Alessandro
    Cavo, Michele
    Latagliata, Roberto
    De Stefano, Valerio
    CANCERS, 2023, 15 (14)
  • [44] Disease, clinical, and treatment characteristics of patients (pts) with polycythemia vera (PV) enrolled in the REVEAL study.
    Grunwald, Michael Richard
    Stein, Brady
    Moliterno, Alison
    Boccia, Ralph V.
    Oh, Stephen T.
    Naim, Ahmad Bilal
    Cordaro, Joseph A.
    Peng, Wei
    Sun, Hao
    Parasuraman, Shreekant
    Mesa, Ruben A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] A phase II trial to assess the efficacy and safety of ropeginterferon α-2b in Chinese patients with polycythemia vera
    Jin, Jie
    Qin, Albert
    Zhang, Lei
    Shen, Weihong
    Wang, Wei
    Zhang, Jingjing
    Li, Yaning
    Wu, Daoxiang
    Xiao, Zhijian
    FUTURE ONCOLOGY, 2023, 19 (11) : 753 - 761
  • [46] Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera - Final Phase I/II Peginvera Study Results
    Gisslinger, Heinz
    Buxhofer-Ausch, Veronika
    Thaler, Josef
    Forjan, Ernst
    Willenbacher, Ella
    Wolf, Dominik
    Kralovics, Robert
    Gisslinger, Bettina
    Stampfl-Mattersberger, Margarete
    Egle, Alexander
    Melchardt, Thomas
    Burgstaller, Sonja
    Schalling, Martin
    Krauth, Maria-Theresa
    Greil, Richard
    Kadlecova, Pavla
    Zoerer, Michael
    Empson, Victoria
    Grohmann-Izay, Barbara
    Klade, Christoph
    BLOOD, 2018, 132
  • [47] Successful Treatment of HU-Refractory Polycythemia Vera with Atorvastatin and Low Dose Hydroxyurea. Results from a Pilot Study in Bolivia
    Amaru, Ricardo
    Amaru, Ariel
    Miguez, Hortensia
    Torres, Gina
    Mamani, Josue
    Aguilar, Maria
    Cuevas, Heriberto
    BLOOD, 2015, 126 (23)
  • [48] A Phase 2 Study of Ruxolitinib, an Oral JAK1 and JAK2 Inhibitor, in Patients With Advanced Polycythemia Vera Who Are Refractory or Intolerant to Hydroxyurea
    Verstovsek, Srdan
    Passamonti, Francesco
    Rambaldi, Alessandro
    Barosi, Giovanni
    Rosen, Peter J.
    Rumi, Elisa
    Gattoni, Elisabetta
    Pieri, Lisa
    Guglielmelli, Paola
    Elena, Chiara
    He, Shui
    Contel, Nancy
    Mookerjee, Bijoyesh
    Sandor, Victor
    Cazzola, Mario
    Kantarjian, Hagop M.
    Barbui, Tiziano
    Vannucchi, Alessandro M.
    CANCER, 2014, 120 (04) : 513 - 520
  • [49] Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study
    Alessandro Rambaldi
    Alessandra Iurlo
    Alessandro M. Vannucchi
    Richard Noble
    Nikolas von Bubnoff
    Attilio Guarini
    Bruno Martino
    Antonio Pezzutto
    Giuseppe Carli
    Marianna De Muro
    Stefania Luciani
    Mary Frances McMullin
    Nathalie Cambier
    Jean-Pierre Marolleau
    Ruben A. Mesa
    Raoul Tibes
    Alessandro Pancrazzi
    Francesca Gesullo
    Paolo Bettica
    Sara Manzoni
    Silvia Di Tollo
    Leukemia, 2020, 34 : 2234 - 2237
  • [50] Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study
    Rambaldi, Alessandro
    Iurlo, Alessandra
    Vannucchi, Alessandro M.
    Noble, Richard
    von Bubnoff, Nikolas
    Guarini, Attilio
    Martino, Bruno
    Pezzutto, Antonio
    Carli, Giuseppe
    De Muro, Marianna
    Luciani, Stefania
    McMullin, Mary Frances
    Cambier, Nathalie
    Marolleau, Jean-Pierre
    Mesa, Ruben A.
    Tibes, Raoul
    Pancrazzi, Alessandro
    Gesullo, Francesca
    Bettica, Paolo
    Manzoni, Sara
    Di Tollo, Silvia
    LEUKEMIA, 2020, 34 (08) : 2234 - 2237
12345